Improved outcomes in women with BRAF-mutant melanoma treated with BRAF/MEK-targeted therapy across randomized clinical trials. A systematic review and meta-analysis. (October 2022) - Pala, L.; De Pas, T.; Pagan, E.; Catania, C.; Bagnardi, V.; Conforti, F.